Myopia

Mandy Sallach, OD, overviews initiatives being taken on by the company to combat pediatric myopia.

Drs Clark Chang and Tracy Lynn Schroeder Swartz give an overview of their Optometry's Meeting talk on detecting keratoconus early, providing tips for the proper technology to use and how to properly detect high-risk patients.

Over 60 eye care professionals from all 50 states were selected to help shift the focus of pediatric myopia care from correction to comprehensive treatment.

The company’s initiatives include involvement with the Global Myopia Awareness Coalition and discounting blue light screen protectors and its pediatric eye care program, among others.

Investigators found more cases than expected following tomography of 2007 eyes.

MyopiaX is a non-invasive, light-based treatment that uses a virtual reality headset to deliver treatment while patients engage with digital content.

Representatives from CooperVision and the International Agency for the Prevention of Blindness give a preview of what to expect at the "Universal Access to Glasses: Promoting Multisectoral Action" event at this year's World Health Assembly in Geneva, Switzerland.

Noel Brennan, MScOptom, PhD, overviews his ARVO 2024 presentation on reimagining the prediction of longer term efficacy numbers in data from pediatric trials evaluating myopia.

Ricardo Pintor, OD, FIACLE, gives an overview of the World Council of Optometry’s first Latin America–based virtual event and what challenges Latin America faces in terms of myopia.

CIME Cochair Neda Shamie, MD, gives an overview of presentations on Demodex blepharitis, LASIK, retina sessions, and more at this year's conference.

This study also found that upon discontinuation, myopia development did not rebound, with NVK002 0.01% as a potential long-term treatment for pediatric myopia.

David A. Berntsen, OD, PhD, FAAO, talks through his 2024 ARVO presentation on the BLINK2 study and the findings on axial growth after discontinuing soft multifocal contact lens wear.

The Diffusion Optics Technology, or DOT 0.2, works by utilizing thousands of light scattering elements to mimic natural contrast on the retina, which can slow myopia progression in child, according to the company.

The technology works by concentrating a specific band of light, typically 650 nm, into a laser beam to irradiate the retina.

The important role eye care providers play in lessening the burden of myopia treatment for pediatric specialists.

Michele Andrews, OD, vice president of professional and government affairs for CooperVision, and Terri A. Gossard, OD, MS, member of the AOA board of trustees, sat down with Optometry Times to discuss the goals and tactics of The Myopia Collective.

The World Council of Optometry partners with key optometric organizations for 2025 conference and appoints expert leaders in myopia management for education and outreach.

What axial length readings and crystalline lens power tell you.

Control measures in China are ahead of US measures.

The optometry school, founded in 1904, was the first of its kind in California.

The company, which has completed each of its CLARITY trials for both eye drops, will be reporting on their findings next month.

The Russian study also found that the aging of a young myopic generation may result in even more visual impairment and blindness as the result of myopic macular degeneration.

As myopia prevalence continues to increase, there is a growing concern about myopia’s economic burden and effects on children, specifically on their visual impairment and quality of life. The consequences of myopia and high myopia can be delayed by implementing myopia management therapies.

Dr Brianna Rhue, OD, FAAO, FSLS details her upcoming presentation "Cutting Out Surgery for the Management of Refractive Error," where she will detail the underutilization of orthokeratology during Vision Expo East 2024 later this week.

R Tracy Williams, OD, FAAO, reflects on his favorite stories working as a team optometrist for the Chicago Bulls and Chicago White Sox in the last 20 years.

The prevailing message is that physicians have “a long way to go” in the optimization of management and prevention of myopic vitreoretinal disease.

Diffusion Optics Technology (DOT) spectacle lenses are intended to slow myopia progression in children via contrast management mechanism of action.

Myopia management in children is a crucial step to ensuring the overall health and wellness of our youth.

A new study out of Guangzhou, China found that individuals younger than 18 years of age and experiencing high myopia are at a high risk of progressively worsening myopic maculopathy.